Modulation of the Kcnn4 channel represent a potentially therapeutic approach for skeletal pathologic conditions such as multiple sclerosis, inflammatory arthritis, and osteoporosis [15,28,31]. This evidence concerns the gene KCNN4 and osteoporosis.